Antonia Busse

6PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Oct 20, 2025
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

M Korenkov, J Liebaert, S Yousefian

|Oct 16, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.

Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert

|Feb 11, 2023
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.

Paul Schossig, Ebru Coskun, Ruza Arsenic

|Apr 12, 2022
Isolation of Neoantigen-Specific Human T Cell Receptors from Different Human and Murine Repertoires.

Corinna Grunert, Gerald Willimsky, Caroline Anna Peuker

|Nov 24, 2020
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.

Antonia Busse, Liliana H Mochmann, Christiane Spenke

Pageof 1

Frequent Collaborators

5 joint publications

Ulrich Keller

2 joint publications

Uta Margareta Demel

2 joint publications

Neşe Çakmak-Görür

2 joint publications

Simone Rhein